1.
Clinical significance of multiple tumor marker protein chip detective system and diagnostic function in diagnosis of female tumors
多肿瘤标志物蛋白芯片检测及判别函数在妇科肿瘤诊断中的应用
2.
Value analysis of combined measurement of multi-tumor markers in malignant tumor diagnosis
多肿瘤标志物联合检测在恶性肿瘤诊断中的价值分析
3.
Screening and Application of Associtive Marker Diagnosing Lung Cancer From Protein Chip Multi-Tumor Markers
多肿瘤标志物蛋白芯片诊断肺癌指标的筛查及应用
4.
The Application of Multi-Tumor Marker Protein Chip Assistance Diagnostic System in Clinic;
多肿瘤标志物蛋白芯片检测系统在临床中的应用
5.
About the Evidence of Tumor Marker in Tumor Studies
肿瘤与肿瘤标志物研究中证据的思考
6.
Clinical Significance of Combined Detection of Serum Levels of Multiterm Tumor Markers in Patients with Upper Gastrointestinal Cancer
上消化道恶性肿瘤患者血清多项肿瘤标志物联合检测的临床意义
7.
STUDY OF MULTI-TUMOR MARKERS COMBINING DETECTION IN THE DIAGNOSIS OF DIGESTIVE SYSTEM MALIGNANT TUMOR
多种肿瘤标志物联合检测在消化道恶性肿瘤诊断中的研究
8.
The Clinical Value of Detecting Tumor Multi-Markers in Pleural Effusion
胸水多项肿瘤标志物联合检测的临床价值
9.
The application of serum tumor markers for pancreatic cancer in clinical stage assessment and preoperative evaluation
多种肿瘤标志物在胰腺癌临床分期中的应用
10.
Relationship Between Tumor Markers and Clinical Outcomes in Gastric Cancer
多种肿瘤标志物与胃癌进展及预后的关系
11.
Preparation of Freezen Dried Quality Control Sample with Multiple Tumor Markers
多项目复合肿瘤标志物冻干质控品的制备
12.
Multi-cutoff level setting algorithm for various tumors markers in colorectal cancer
结直肠癌肿瘤标志物多分割点设置算法
13.
Tumor type M2 pyruvate kinase-the new tumor marker in colorectal cancer
结直肠恶性肿瘤的新标志物—肿瘤型丙酮酸激酶
14.
Diagnostic significance of CA19-9 in digestive system cancer
肿瘤标志物CA19-9在消化道肿瘤诊断中的应用
15.
Cap43 as a Tumor Marker in Nickel Induced Lung Cancer;
Cap43作为镍接触肺癌肿瘤标志物的研究
16.
Screening and Functional Studies of Novel Tumor Markers
新肿瘤标志物的筛选及功能初步研究
17.
An Update of Biomarkers in Prostate Cancer Tissue
前列腺癌组织学肿瘤标志物研究进展
18.
Detection of serum protein biomarkers by surface enhancedlaser desorption ionization time of flight mass spectrometry(SELDI-TOF-MS) in patients with non-small cell lung cancer
SELDI-TOF-MS技术筛选NSCLC血清肿瘤标志物